Apogee’s APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B is ongoing.
Apogee Therapeutics’ Eczema Drug Provides Rapid Itch Relief In Phase 2 Trial
Where Today's News Shapes Tomorrow
